Skip to main content
Clinical Trials/DRKS00031139
DRKS00031139RecruitingNot Applicable

Identification and analysis of biomarkers for the course of demyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosis - GRAMS

MPI-NAT0 sites1,000 target enrollmentStarted: January 26, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
1,000

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
16 Years to one (—)
Sex
All

Inclusion Criteria

  • •Diagnosis Multiple Sclerosis or other demyelinating diseases of the CNS

Exclusion Criteria

  • Not provided

Investigators

Sponsor
MPI-NAT

Similar Trials